Share
Close
Select Where You Want To Share:
Go Ahead and Share This Blog and Watch The Views Soar!
Shared Blogs Receive 98% More Views!
This Blog Has Been PowerShared™ Successfully!
XOMA Corp (XOMA) FDA Orphan Drug Designation for a Rare Neutrophilic Dermatosis, zulily (ZU) Strong Results : https://www.storeboard.com/blogs/business/xoma-corp-xoma-fda-orphan-drug-designation-for-a-rare-neutrophilic-dermatosis-zulily-zu-strong-results/270759
Share
Sharing, Please Wait...
XOMA Corp (XOMA) FDA Orphan Drug Designation for a Rare Neutrophilic Dermatosis, zulily (ZU) Strong Results
https://www.storeboard.com/blogs/business/xoma-corp-xoma-fda-orphan-drug-designation-for-a-rare-neutrophilic-dermatosis-zulily-zu-strong-results/270759
XOMA reported that its gevokizumab has been granted Orphan Drug Designation by the U.S. FDA for the treatment of pyoderma gangrenosum
Click Here To View This Blog
